# FDA Inspection 830516 - Boston IVF at The Women's Hospital - May 06, 2013

Source: https://www.keypedia.com/records/fda_inspections/boston-ivf-at-the-womens-hospital/f2406ea2-73cd-46fa-94ff-c484e0fd6600
Source feed: FDA_Inspections

> FDA Inspection 830516 for Boston IVF at The Women's Hospital on May 06, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 830516
- Company Name: Boston IVF at The Women's Hospital
- Inspection Date: 2013-05-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1280953 - 2025-09-09](https://www.keypedia.com/records/fda_inspections/boston-ivf-at-the-womens-hospital/89a3e5aa-6d1c-423b-9c1e-fa80eb57dae9)
- [FDA Inspection 1168585 - 2022-04-05](https://www.keypedia.com/records/fda_inspections/boston-ivf-at-the-womens-hospital/291efc19-ac51-4b21-bc29-922bec483e90)
- [FDA Inspection 1168585 - 2022-04-05](https://www.keypedia.com/records/fda_inspections/boston-ivf-at-the-womens-hospital/ac73a5a3-6bed-4917-be10-228709ce8194)
- [FDA Inspection 1021251 - 2017-08-09](https://www.keypedia.com/records/fda_inspections/boston-ivf-at-the-womens-hospital/0e6f1f8d-4980-41c7-9ab4-8fb87f106b3c)
- [FDA Inspection 1021251 - 2017-08-09](https://www.keypedia.com/records/fda_inspections/boston-ivf-at-the-womens-hospital/4a1fe32d-48f5-4ea9-8bd4-437af8c43fd9)

Company: https://www.keypedia.com/companies/boston-ivf-at-the-womens-hospital/b233d5d2-5819-4a94-bf11-ef47dd9f4d81

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d